HiberCell Competitors and Similar CompaniesClear all
Eisbach Bio's competitors and similar companies include PEP-Therapy.
 Eisbach Bio Eisbach Bio is a company that develops drugs to target molecular vulnerabilities arising in cancer genomes. |  PEP-Therapy PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer. | |
Founding Date | Founding Date 2019 | Founding Date 2014 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Planegg, DE HQ | Locations Paris, FR HQ Évry, FR |
Employees | Employees 118% decrease | Employees 14 |
For sources of this data, please see the company profile
View Company Profiles
PEP-Therapy
HQ
Paris, FR
Employees
14
PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer.
View company